Globus Medical, Inc.
GMEDI almost skipped this one. Globus Medical, GMED, stamps spinal hardware surgeons trust, and across seven lenses, the rank is ahead of ninety-odd others. Revenue growth revised near thirty-six percent, insiders still sold.
- Fair value according to the model23.0% above the priceThe model puts fair value 23.0% above today's price. It weighs earnings, growth and risk.
- How it ran against the rest78.5%Over the past period this stock did better than 78% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
- Can the company take a hitstrong balance sheetA widely used bankruptcy test scores this company 9.8. Above 3 counts as solid, below 1.8 as fragile. This balance sheet can absorb a bad year.
- Are profits growing too+422% profitProfit changed by 422 percent against 17 percent of revenue. Profit is growing faster than revenue, which is exactly what you want to see: the company gets more efficient as it grows.
- Is revenue still growing+16.6% in a yearRevenue grew 16.6 percent over the past year. That is the foundation under everything above.